WHAT IS KNOWN ABOUT TUMOR PROLIFERATION RATES TO CHOOSE BETWEEN ACCELERATED FRACTIONATION OR HYPERFRACTIONATION

被引:168
作者
TROTT, KR
KUMMERMEHR, J
机构
关键词
D O I
10.1016/S0167-8140(85)80002-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 9
页数:9
相关论文
共 44 条
[1]  
BASERGA R, 1962, LAB INVEST, V11, P360
[2]  
BRENNER D, 1984, THESIS U MUNCHEN
[3]  
BUNEMANN H, 1973, STRAHLENTHER ONKOL, V146, P155
[4]  
COOPER E. H., 1966, EUR J CANCER, V2, P377, DOI 10.1016/0014-2964(66)90052-1
[5]   IN-VITRO AND IN-VIVO LABELING OF ANIMAL TUMORS WITH TRITIATED-THYMIDINE [J].
DENEKAMP, J ;
KALLMAN, RF .
CELL AND TISSUE KINETICS, 1973, 6 (03) :217-227
[6]  
ENTHAMMER G, 1978, THESIS U MUNCHEN
[7]   ANALYSIS OF THE PARAMETERS RELATING TO FAILURES ABOVE THE CLAVICLES IN PATIENTS TREATED BY POSTOPERATIVE IRRADIATION FOR SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY OR OROPHARYNX [J].
FELDMAN, M ;
FLETCHER, GH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (01) :27-30
[8]  
Fletcher G, 1980, TXB RADIOTHERAPY
[9]   HODGKINS DISEASE - TUMOR LETHAL DOSE AND ISO-EFFECT RECOVERY CURVE [J].
FRIEDMAN, M ;
PEARLMAN, AW ;
TURGEON, L .
AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1967, 99 (04) :843-&
[10]  
HAINAU B, 1974, CANCER-AM CANCER SOC, V33, P115, DOI 10.1002/1097-0142(197401)33:1<115::AID-CNCR2820330118>3.0.CO